Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese drug composition for treating macular degeneration, and preparation method thereof

A technology for the treatment of macular degeneration and composition, which is applied in the direction of drug combinations, pharmaceutical formulas, and medical preparations containing active ingredients, etc. It can solve the problem of safe and reliable Chinese patent medicines, patients who cannot tolerate long-term medication, and dry macular degeneration that cannot be treated. problems, to achieve significant curative effect, to treat central serous chorioretinopathy, and to treat optic atrophy

Active Publication Date: 2011-09-21
吴幼锐
View PDF2 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Both Lucentis and Avastin have their disadvantages: 1. Both need to penetrate the eyeball and inject into the eye
The above two points determine that the patient cannot tolerate long-term medication; 3. These two drugs cannot treat dry macular degeneration
[0009] Traditional Chinese medicine has been adopted by many Chinese medicine practitioners in the treatment of macular degeneration, but so far there is no Chinese patent medicine with ideal effect and safe and reliable for patients to enjoy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese drug composition for treating macular degeneration, and preparation method thereof
  • Traditional Chinese drug composition for treating macular degeneration, and preparation method thereof
  • Traditional Chinese drug composition for treating macular degeneration, and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] A traditional Chinese medicine composition for treating macular degeneration, its components and dosage are as follows:

[0043] Name (concentrated powder)

[0044] The medicinal powders of the above-mentioned components are mixed evenly according to the dosage relationship, and the mixed medicinal powders are packed into non-toxic medicinal paper bags, and each paper bag is equipped with 5.0 g of medicinal powders.

Embodiment 2

[0046] A traditional Chinese medicine composition for treating macular degeneration, its components and dosage are as follows:

[0047] Name (concentrated powder)

[0048] Get the medicated powders of the above-mentioned components and mix them uniformly according to the dosage relationship, and pack the mixed medicated powders into No. 0 capsules, each capsule containing 0.5 g of the medicated powders.

Embodiment 3

[0050] A traditional Chinese medicine composition for treating macular degeneration, its components and dosage are as follows:

[0051] Name (concentrated powder)

[0052] Take the medicated powders of the above-mentioned components and mix them evenly according to the dosage relationship.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a traditional Chinese drug composition for treating macular degeneration, and a preparation method thereof. The traditional Chinese drug composition comprises, by weight, 0.8-3.0 parts of dan-shen root, 0.3-2.0 parts of szechwan lovage rhizome, 0.6-2.4 parts of barbury wolfberry fruit, 0.5-2.0 parts of chrysanthemum, 0.2-1.2 parts of Chinese magnoliavine fruit, 0.9-6.0 parts of lalang grass rhizome and 0.5-2.0 parts of baikal skullcap root. The preparation method comprises uniformly mixing concentrated medicine powders of each component according to t he relationship among the amount of each component. The traditional Chinese drug has significant effect for treating the macular degeneration, and only requires oral administration. Treatment effectiveness of the traditional Chinese drug for treating the wet macular degeneration is similar to the treatment effectiveness of western medicine Lucentis and Avastin for treating the wet macular degeneration while the traditional Chinese drug has no side effects of the western medicine. In addition, the traditional Chinese drug has the same good treatment effectiveness for treating dry macular degeneration as the treatment effectiveness for treating the wet macular degeneration, such that problem of failure of treating the dry macular degeneration by the existing western medicine is solved.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition and a preparation method thereof, in particular to a traditional Chinese medicine composition for treating macular degeneration and a preparation method thereof. Background technique [0002] Macular degeneration is the leading cause of vision loss in adults over the age of 45 in all countries of the world. Its pathogenesis has not been fully elucidated, but it is currently known to be related to genetic factors, aging of the pigment epithelium and nerve tissue in the macular area, long-term light damage in the macular area, insufficient blood and oxygen supply in the macular area caused by blood circulation disorders, and hypertrophy of the macular structure caused by free radicals. Oxidative damage is related to toxic damage such as alcohol, tobacco, and drugs. [0003] Macular degeneration can be divided into dry and wet. Dry macular degeneration accounts for 90% and wet macular de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P27/02A61K31/357
CPCA61K36/537A61K36/899A61K36/804A61K36/287A61K31/357A61K36/79A61K36/815A61P27/02A61K2300/00
Inventor 吴幼锐
Owner 吴幼锐
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products